| ［1］ |
McNeil EP, Goldfarb N, Hannon GR, et al. Mycobacterium immunogenum folliculitis on the lower extremities of a healthy young adult［J］. Clin Exp Dermatol, 2019,44（3）:328⁃330. doi: 10.1111/ced.13703.
|
| ［2］ |
Falkinham JO 3rd. Environmental sources of nontuberculous mycobacteria［J］. Clin Chest Med, 2015,36（1）:35⁃41. doi: 10. 1016/j.ccm.2014.10.003.
|
| ［3］ |
Griffith DE, Aksamit T, Brown⁃Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases［J］. Am J Respir Crit Care Med, 2007,175（4）:367⁃416. doi: 10.1164/rccm.200604⁃571ST.
|
| ［4］ |
Bhattacharya J, Mohandas S, Goldman DL. Nontuberculous mycobacterial infections in children［J］. Pediatr Rev, 2019,40（4）:179⁃190. doi: 10.1542/pir.2018⁃0131.
|
| ［5］ |
Wilson RW, Steingrube VA, Böttger EC, et al. Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo⁃outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy［J］. Int J Syst Evol Microbiol, 2001,51（Pt 5）:1751⁃1764. doi: 10. 1099/00207713⁃51⁃5⁃1751
|
| ［6］ |
Mitchell CB, Isenstein A, Burkhart CN, et al. Infection with Mycobacterium immunogenum following a tattoo［J］. J Am Acad Dermatol, 2011,64（5）:e70⁃e71. doi: 10.1016/j.jaad.2009.12.037.
|
| ［7］ |
Del⁃Castillo M, Palmero D, Lopez B, et al. Mesotherapy⁃associated outbreak caused by Mycobacterium immunogenum［J］. Emerg Infect Dis, 2009,15（2）:357⁃359. doi: 10.3201/eid 1502.081125.
|
| ［8］ |
林雅燕, 程波, 陈丽红, 等. 四例皮肤非结核分枝杆菌感染临床分析［J］. 中华皮肤科杂志, 2018,51（6）:463⁃464. doi: 10. 3760/cma.j.issn.0412⁃4030.2018.06.018.
|
| ［9］ |
Yeon J, Chan RC, Fallah H. Infection with Mycobacterium immunogenum following botulinum toxin injection［J］. Australas J Dermatol, 2021,62（1）:79⁃80. doi: 10.1111/ajd.13406.
|
| ［10］ |
Holden IK, Kehrer M, Andersen AB, et al. Mycobacterium marinum infections in Denmark from 2004 to 2017: a retrospective study of incidence, patient characteristics, treatment regimens and outcome［J］. Sci Rep, 2018,8（1）:6738. doi: 10.1038/s41598⁃018⁃24702⁃7.
|
| ［11］ |
Brown⁃Elliott BA, Wallace RJ Jr. In vitro susceptibility testing of tedizolid against nontuberculous mycobacteria［J］. J Clin Microbiol, 2017,55（6）:1747⁃1754. doi: 10.1128/JCM.00274⁃17.
|
| ［12］ |
Sun K, Yang H, Huang X, et al. ALA⁃PDT combined with antibiotics for the treatment of atypical mycobacterial skin infections: outcomes and safety［J］. Photodiagnosis Photodyn Ther, 2017,19:274⁃277. doi: 10.1016/j.pdpdt.2017.06.015.
|
